Tower Research Capital (TRC)’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-7,398
| Closed | -$43K | – | 6665 |
|
2022
Q4 | $43K | Buy |
7,398
+5,351
| +261% | +$31.1K | ﹤0.01% | 2480 |
|
2022
Q3 | $14K | Sell |
2,047
-27,165
| -93% | -$186K | ﹤0.01% | 4246 |
|
2022
Q2 | $123K | Buy |
29,212
+4,205
| +17% | +$17.7K | ﹤0.01% | 2131 |
|
2022
Q1 | $84K | Buy |
25,007
+11,316
| +83% | +$38K | ﹤0.01% | 2348 |
|
2021
Q4 | $44K | Buy |
13,691
+10,366
| +312% | +$33.3K | ﹤0.01% | 2871 |
|
2021
Q3 | $11K | Sell |
3,325
-2,975
| -47% | -$9.84K | ﹤0.01% | 4281 |
|
2021
Q2 | $27K | Sell |
6,300
-4,391
| -41% | -$18.8K | ﹤0.01% | 3621 |
|
2021
Q1 | $53K | Buy |
10,691
+5,224
| +96% | +$25.9K | ﹤0.01% | 3080 |
|
2020
Q4 | $69K | Sell |
5,467
-24,751
| -82% | -$312K | ﹤0.01% | 2744 |
|
2020
Q3 | $297K | Buy |
30,218
+25,104
| +491% | +$247K | ﹤0.01% | 2201 |
|
2020
Q2 | $51K | Buy |
+5,114
| New | +$51K | ﹤0.01% | 3037 |
|
2020
Q1 | – | Sell |
-409
| Closed | -$4K | – | 4190 |
|
2019
Q4 | $4K | Sell |
409
-272
| -40% | -$2.66K | ﹤0.01% | 2842 |
|
2019
Q3 | $4K | Buy |
+681
| New | +$4K | ﹤0.01% | 3487 |
|
2019
Q2 | – | Sell |
-288
| Closed | -$3K | – | 4509 |
|
2019
Q1 | $3K | Sell |
288
-635
| -69% | -$6.62K | ﹤0.01% | 3340 |
|
2018
Q4 | $12K | Buy |
+923
| New | +$12K | ﹤0.01% | 2350 |
|
2018
Q3 | – | Sell |
-4,537
| Closed | -$76K | – | 4393 |
|
2018
Q2 | $76K | Buy |
+4,537
| New | +$76K | ﹤0.01% | 1610 |
|
2017
Q4 | – | Sell |
-3,456
| Closed | -$51K | – | 4291 |
|
2017
Q3 | $51K | Buy |
+3,456
| New | +$51K | ﹤0.01% | 1965 |
|
2017
Q1 | – | Sell |
-3,998
| Closed | -$41K | – | 4161 |
|
2016
Q4 | $41K | Buy |
+3,998
| New | +$41K | ﹤0.01% | 1562 |
|
2016
Q1 | – | Sell |
-456
| Closed | -$9K | – | 5183 |
|
2015
Q4 | $9K | Buy |
+456
| New | +$9K | ﹤0.01% | 2318 |
|
2014
Q3 | – | Sell |
-3,169
| Closed | -$32K | – | 5037 |
|
2014
Q2 | $32K | Buy |
3,169
+1,503
| +90% | +$15.2K | ﹤0.01% | 1567 |
|
2014
Q1 | $22K | Buy |
+1,666
| New | +$22K | ﹤0.01% | 1800 |
|